# Monopar Therapeutics: Form 8-K, filed May 14, 2026

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: 8-K
- Filed: 2026-05-14
- Accepted by EDGAR: May 14, 2026, 14:00 ET
- Period: 2026-05-14
- Accession: 0001437749-26-016981
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774926016981/mnpr20260513c_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774926016981/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774926016981/mnpr20260513c_8k.htm

Filed May 14, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-016981. Last ingested by Listed: Nov 4, 2026, 20:49 ET. No prices; not investment advice.